KMK.V.N.S. Manikanta

K.V.N.S. Manikanta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


K.V.N.S. Manikanta has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Alok Jain

    Advanced BioComputing Lab, Department of Bioengineering and Biotechnology, Birla Institute of Technology Mesra, Ranchi 835215, Jharkhand, India

    1 shared publication
  • Amit Shard

    Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), Gandhinagar, Gujarat, India

    1 shared publication
  • Anwesha Das

    Department of Pharmacy, Sanaka Educational Trust Group of Institutions (SETGOI), Durgapur, West Bengal, 713212, India

    1 shared publication
  • Arnab Chowdhury

    Biomimetic Peptide Engineering Lab, Department of Chemistry, Indian Institute of Technology Ropar, Bara Phool, Rupnagar, India

    1 shared publication
  • Bhagyashri Rathod

    School of Pharmacy and Technology Management SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Deemed‐to‐be University Jadcherla Telangana India

    1 shared publication
  • Deep Rohan Chatterjee

    Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Opposite Airforce station, Palaj, Gandhinagar, Gujarat – 382355, India

    1 shared publication

Latest Publications

  • Open Access

    Effect of the G-Protein-Coupled Receptor T2R14 on Proliferation and Cell Population Growth in Oral Cancer Cells

    by Yongqiang Chen, Manikanta Kella, Kayla Austin, Rajinder P. Bhullar, Prashen Chelikani

    Oral cancer is a leading cause of cancer-related deaths and significantly affects the quality of life of patients. However, many of its mechanisms remain unclear, and its treatment needs improvement. The G-protein-coupled receptor taste receptor type 2 member 14 (T2R14 or TAS2R14) is expressed in various cancer types. However, few studies have investigated its roles in oral cancer, and its effects on oral cancer cell proliferation and growth are unknown. This study aimed to examine T2R14’s impact on proliferation and cell population growth (CPG) of oral cancer cells. TAS2R14 gene knockout was performed, and cell numbers, cell viability, and colony formation were measured. This study showed that TAS2R14 knockout in oral cancer cells significantly decreased calcium mobilization, increased cell numbers, colony formation, the proliferation marker proliferating cell nuclear antigen, and the phosphorylation of mechanistic target of rapamycin, but did not affect cell viability. These observations are consistent with the clinical data that higher TAS2R14 mRNA expression is associated with better survival of patients with oral cancer. Therefore, T2R14 downregulation increased oral cancer CPG, suggesting a tumor-suppressor-like role. The study’s findings could improve our understanding of T2R14 mechanisms and help develop strategies to advance oral cancer treatment by targeting T2R14.


  • Design and synthesis of novel quinazolinone-based pyruvate kinase M2 activators as selective inhibitors of oral cancer cells

    by Bhagyashri Rathod, Swarali Joshi, Siddulu Regu, K.V.N.S. Manikanta, Hansal Kumar, Samdisha Dubey, Arnab Chowdhury, Raisa Parveen Shaikh, Anwesha Das, Sagarkumar Patel, et al.